The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. There is no assurance or guarantee that the scheme's objectives will be realised. This product is suitable for investors who are...
- 10-Nov-25
